A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

(Steve Gschmeissner/Brand X Pictures/Getty Images) As ovaries age, their supporting tissue becomes stiffer, and slowing that ...

Most uterine cancers have excellent five-year survival rates—up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer.

Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...

Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic ...

Most women are aware that fertility declines dramatically with age. This is mainly due to the gradual loss of eggs and ...

New research yields a novel method to use ultrasound to enhance machine learning's ability to accurately diagnose -- or rule out -- ovarian cancer. Although ovarian cancer is the deadliest type of ...

In a prospective cohort study, the ultrasound-based International Ovarian Tumour Analysis (IOTA) Assessment of Different Neoplasias in the adnEXa (ADNEX) model at a threshold of 10% demonstrated ...